EarningsQ1 2026 Earnings Report

Outlook Therapeutics (41O) Q1 2026 Earnings Report

8 Followers

DE:41O Q1 2026 EPS Results

Actual EPS-€0.19

Consensus EPS-€0.20

Beat/MissBeat by +<€0.01

One Year Ago EPS-€0.77

Actual Revenue-€1.04M

Expected Revenue€2.71M

Beat/MissMissed by -€3.76M

YoY Revenue Growth―

QuarterQ1 2026

Date02/17/2026

TimeBefore Open

Conference CallTuesday, February 17, 2026

DE:41O Upcoming Earnings

Outlook Therapeutics's next earnings date is estimated for December 18, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Dec 18, 2026	2026 (Q4)	-0.06 / -	-0.052	―
Aug 14, 2026	2026 (Q3)	-0.07 / -0.08	-0.38	79.55% (+0.30)
May 15, 2026	2026 (Q2)	-0.10 / -0.14	-0.345	60.00% (+0.21)
Feb 17, 2026	2026 (Q1)	-0.20 / -0.19	-0.768	75.28% (+0.58)
Dec 19, 2025	2025 (Q4)	-0.22 / -0.05	-0.759	93.18% (+0.71)
Aug 14, 2025	2025 (Q3)	-0.30 / -0.38	-0.716	46.99% (+0.34)
May 15, 2025	2025 (Q2)	-0.47 / -0.35	-1.338	74.19% (+0.99)
Feb 14, 2025	2025 (Q1)	-0.66 / -0.77	-0.69	-11.25% (-0.08)
Dec 27, 2024	2024 (Q4)	-0.69 / -0.76	-0.863	12.00% (+0.10)
Aug 14, 2024	2024 (Q3)	-0.89 / -0.72	-1.381	48.13% (+0.66)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed